Escrow Watch
Creso Pharma (ASX:CPH) is a global medicinal cannabis innovator that develops cannabis and hemp-derived therapeutic, nutraceutical and lifestyle products for both people and animals.
Founded by a team of highly experienced pharmaceutical executives, Creso set out to leverage cutting edge science and research to develop, register and commercialise innovative cannabis and hemp derived products.
It was the first company to import medical cannabis to Australia and it has a presence across Canada, under its subsidiary Mernova, Switzerland and the EU, Israel, Latin America and Australia.
From the outset, Creso’s goal has been to become the world’s most trusted supplier of cannabis and hemp derived products. The company’s experienced pharmaceutical leadership team have an unparalleled track record of success commercialising a wide range of pharmaceutical and therapeutic solutions.
Creso can deliver products with standardised dosing and formulations through the application of pharmaceutical rigour, Good Manufacturing Practices (GMP) standards when appropriate and proprietary, innovative delivery technologies.
As a global company, Creso is not limited by any single market. This enables Creso to offer a diverse portfolio of solutions to the widest possible population.
By partnering with leading global companies in critical areas of research and product development, manufacturing and distribution, Creso has been able to accelerate the development and distribution of approved products allowing for broad access by patients and consumers.
KEY PEOPLE
RELATED STOCKHEAD STORIES
Health & Biotech
Why more small caps are breaking into South American cannabis
Health & Biotech
Weed Week: G-men getting on the hype train
Health & Biotech
Creso extends its global reach with new deal in South Africa
Health & Biotech
Creso receives first commercial CBD export from Colombia ahead of PharmaCielo acquisition
News
Weed Week: Federal government takes steps to fast track medical marijuana licences
Health & Biotech
Creso just locked in a New Zealand distribution deal for its CBD products
Health & Biotech
Creso receives first order of its cannaQIX 50 pain relief lozenges from Burleigh Heads
Health & Biotech
Creso posts nearly $1m in six-month revenue ahead of acquisition
News
Weed week: cannabis is about to get scary in Canada
Health & Biotech
Weed Week: Here comes the latest hot take on legal dope from… the Country Women’s Association
News
Top 10 at 10: These ASX stocks have leapt out of the blocks today
Health & Biotech
Canadian shareholder buys Aussie pot stock Creso Pharma for $122m
News
Weed Week: Which of you were forced to sell your beloved pot stocks last week?
Health & Biotech
Creso’s whole plant approach maximises the potential of medicinal cannabis
News
IG Markets looked at almost 1000 pot stocks before deciding to ban 19
Food & Agriculture
The Pot Seat: LeafCann’s Elisabetta Faenza 86’d all licence apps and came out okay
Health & Biotech